ABSTRACT
Oral Squamous Cell Carcinoma (OSCC) is common preventable disease when diagnosed early, but mostly its progression follows transition from oral potentially malignant disorders (OPMDs) like Oral Submucous Fibrosis (OSF). However, it is difficult to predict possibilities of progression in these premalignant lesions hence, identification of molecular biomarkers would have major clinical impact in early diagnosis and better prognosis. In this context microRNA’s(miR’s) provide better opportunities in malignancy prediction and demarcation in OSF to OSCC transition as they perform key regulatory roles in many tumorigenic processes. Here, we computationally screened differentially expressed miR’s of OSCC and OSF from public databases followed by construction of protein interaction networks and enrichment analyses. The relevant miR’s were validated using qPCR of total 93 samplesincluding 34 OSCC, 30 OSF and 29 control blood and tissue samples. We identified significant down regulation of miR-133a-3p in OSCC compared to controls and interesting up-regulation compared to OSCC and control. miR-9-5p was up-regulated in OSF as well as OSCC and down-regulated in OSF compared to OSCC. Therefore, these two miR’s may serve as risk stratification biomarkers with validation in larger categorical datasets.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AIIMS/RES(04)/2017/224
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional ethical committee
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
SU, JV, AC, AJ, PP, PE, PP and PS thank AIIMS, Jodhpur for financial support and research facilities, SD thank AIIMS, Gorakhpur for financial support, CC thank DST-INSPIRE research grant and Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research, Chandigarh. SU thank CSIR for financial support in form of CSIR-Senior Research fellowship.
The authors declare no conflicts of interest.
The figures in pdf were not clear
Data Availability
supplimentary data
ABBREVATIONS
- OSCC
- Oral squamous cell carcinoma
- HNSCC
- Head and neck cancer
- OPMDs
- Oral potentially malignant disorders
- OSF
- Oral submucous fibrosis
- EMT
- Epithelial mesenchymal transition
- HPV
- Human papilloma virus
- miR’s
- microRNA’s